A method of preventing weakness in a patient with Parkinson's disease or of improving or restoring muscle strength of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said muscle strength, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where R] is one of an N-acyl group, a substituted or unsubstiruted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
After equilibration, the proteins were transferred to Immobilon -P PVDF membrane ( EMD Millipore ) using a semidry transfer system ( Bio-Rad , Hercules, CA)
[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Sikiric P., Rucman R., Turkovic B., Sever M., Klicek R., Radic B., Drmic D., Stupnisek M., Misic M., Vuletic L.B., et al
It reliably detects fibroids 5 mm and characterizes their number, size, and location
rather, they suggest which individuals may benefit most from biomarker-guided glutathione or NAC therapy
Then, collected the supernatant which containing cardiomyocytes and transferred into another culture dish with Dulbeccos modified Eagles medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco) and 1% penicillin/streptomycin (Gibco) for 24 h
